Tag: Breast cancer prognosis
News
- 5 years of tamoxifen reduces breast cancer mortality for 15 years for ER+ disease
- African-American and Latina women more likely to start chemotherapy late
- African-American women experience a higher risk of second breast cancer after DCIS
- Age and breast cancer subtype influence prognosis after lumpectomy
- Axillary dissection in patients with occult sentinel lymph node metastases does not improve survival
- Axillary lymph node micrometastases are associated with worse breast cancer prognosis
- Beta blockers and ACE inhibitors might influence risk of breast cancer recurrence
- Beta blockers linked to reduced breast cancer recurrence, especially for triple negative disease
- Beta-blockers might prevent metastasis in breast cancer patients
- Bisphosphonate treatment does not appear to increase survival in early stage breast cancer
- Bisphosphonate Zometa might increase survival in certain premenopausal breast cancer cases
- Bisphosphonates may reduce survival in women with nonmetastatic breast cancer
- Black women less likely to survive ER+/PR+ breast cancer - what to do
- Blood type is not related to breast cancer outcomes
- BMI, type 2 diabetes, and breast cancer prognosis
- Body weight at diagnosis influences breast cancer survival
- Breast cancer diagnosed near pregnancy can be aggressive
- Breast cancer diagnosed within a year of giving birth has unfavorable prognosis
- Breast cancer diagnosis is more common in March and September - what about survival?
- Breast cancer in old age
- Breast cancer patients with high blood sugar levels at diagnosis are more likely to relapse
- Breast cancer prognosis - risk of locoregional recurrence by breast cancer subtype
- Breast cancer prognosis does not depend on whether the tumor is ductal or lobular
- Breast cancer recurrence after five or 10 years
- Breast cancer subtype influences prognosis after neoadjuvant chemotherapy
- Breast cancer type and survival statistics 1999-2004
- Cancer marker CA 15-3 can predict metastasis in women with early stage breast cancer
- Carotenoids in food reduce risk of breast cancer and recurrence
- Change in HER2 status between primary and recurrence indicates poor prognosis
- Characteristics of breast cancer in women under 40
- Chemotherapy improves HER2+ and triple negative outcomes even for small (1cm) tumors
- Cholesterol drugs might inhibit tumor formation in some breast cancer patients
- Cigarette smoking reduces breast cancer survival
- Circulating tumor cells in breast cancer patients linked to poor prognosis
- Circulating vitamin D is not related to risk of breast cancer recurrence
- Clear surgical margins of at least 1 mm reduce rate of local recurrence
- Coexisting DCIS independently predicts lower tumor aggressiveness in luminal breast cancer
- Contralateral mastectomy in BRCA1/2 patients does not improve survival
- Delay in radiation treatment for breast cancer increases risk of local recurrence
- Diabetes accelerates tumor development in a mouse model of HER2+ breast cancer
- Dietary fiber has weak influence on breast cancer prognosis
- Dietary folate is associated with reduced risk of recurrence among women with ER negative tumors
- Dietary trans fat and saturated fat linked to reduced survival after breast cancer
- Differences in hormone receptor status between primary breast tumor and mets is common
- Different breast cancer subtypes are prone to metastasize to different sites in the body
- Early detection with screening mammograms leads to improved breast cancer survival
- Early recurrence more likely with triple negative breast cancer, but risk of recurrence not higher
- Elderly breast cancer patients have good outcomes with appropriate treatment
- Epidermal growth factor receptor (EGFR) expression associated with worse breast cancer prognosis
- ER negative, PR negative, and triple negative tumors have increased risk of locoregional recurrence
- ER+/PR- or ER-/PR+ tumors more likely to recur locally than ER+/PR+ breast cancer
- Exercise before breast cancer diagnosis improves survival
- Exercise before breast cancer makes survival more likely for some women
- Exercise may increase breast cancer survival by altering tumor gene expression
- Exercise reduces inflammation and tumor progression in a mouse model of breast cancer
- Exercise reduces risk of breast cancer recurrence and improves survival
- Explanation for differences in breast cancer outcome based on menstrual cycle at surgery
- Expression of E-cadherin influences prognosis of triple negative breast cancer
- Expression of insulin-like growth factor II may help explain different African-American survival
- Five-year and 10-year survival among young breast cancer patients is better than thought
- Follow-up after breast cancer should take into account risk of relapse
- Green tea consumption may reduce breast cancer recurrence
- Healthy diet can improve prognosis of breast cancer survivors
- Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
- Herceptin increases survival time for Stage IV HER2 breast cancer patients
- High C-reactive protein (CRP) levels linked to unfavorable breast cancer prognosis
- High consumption of lignan-rich foods may improve survival after breast cancer
- High fasting C-peptide levels are linked to reduced survival after breast cancer
- High intake of soy isoflavones increases risk of recurrence in HER2+ patients
- High lignan intake may improve survival among women with ER- breast cancer
- High quality diet can reduce inflammation in breast cancer survivors
- Improvements in overall health after breast cancer may be linked to survival
- Increasingly severe side effects of aromatase inhibitors may make tamoxifen first the best strategy
- Inflammatory breast cancer patients continue to have poorer prognosis
- Intraversion and neuroticism do not increase risk of cancer or influence survival
- Likelihood of death from breast cancer runs in families
- Likelihood of late recurrence for hormone receptor positive breast cancer is hard to predict
- Lobular and ductal breast cancer can be treated similarly based on other important tumor characteristics
- Lobular and ductal breast cancer have different lymph node metastasis patterns
- Locoregional recurrence indicates poor prognosis 10 or more years after lumpectomy
- Long term study finds lower breast cancer-specific death among women with high circulating enterolactone
- Long-term outcomes for DCIS patients can vary significantly according to treatment decisions
- Low circulating vitamin D is associated with more aggressive breast cancer
- Low white blood cell count as a result of chemotherapy indicates the treatment is working
- Luminal breast cancer prognosis can vary based on other tumor characteristics
- Lumpectomy has worse prognosis than mastectomy for young women
- Male breast cancer patients are less likely to survive than female patients
- Male breast cancer survival is influenced by age, tumor size, ER status and lymph node involvement
- Men are more likely to survive breast cancer than women, given similar disease characteristics
- Metformin improves survival of diabetic women with HER2+ breast cancer
- Metformin might reduce growth of breast cancer in postmenopausal obese women
- Mexican breast cancer patients are younger and more likely to have triple negative breast cancer
- Moderate alcohol consumption reduces breast cancer survival for some women
- Modern chemotherapy reduces breast cancer death by about a third compared to no chemotherapy
- Morphine promotes ER+/PR+ and ER-/PR- breast cancer cell migration
- Multifocal breast cancer has worse prognosis than single tumors
- Multivitamins with minerals associated with reduced risk of breast cancer recurrence
- Neutropenia during chemotherapy predicts favorable breast cancer outcome
- New method predicts progression of DCIS to invasive breast cancer
- No need for axillary lymph node dissection when sentinel lymph node biopsy is negative
- Non-anthracycline chemotherapy plus Herceptin is effective treatment for HER2+ breast cancer
- Norway and UK survival differences show need for swift and appropriate treatment
- NSAID given during breast cancer surgery might reduce risk of recurrence
- Number of tumors should be considered in staging multicentric/multifocal breast cancer
- Obesity at diagnosis may reduce survival for ER+ disease, but not ER- disease
- Obesity is linked to inferior prognosis for hormone receptor positive breast cancer
- Obesity not linked to survival in women with triple negative breast cancer
- Obesity reduces breast cancer survival
- Obesity reduces survival after diagnosis and exercise does not improve prognosis
- Obesity reduces survival after early-stage breast cancer
- Obesity reduces survival in women with early breast cancer
- Obesity, smoking and alcohol increase risk of new ER+ tumor in the other breast
- Old women tend to have less aggressive breast cancer and are given less treatment
- Omitting axillary dissection for sentinel node micrometastases means higher risk of recurrence
- Outcomes of breast cancer under age 35 influenced by number of positive lymph nodes
- Ovarian metastases more likely for some groups of breast cancer survivors
- Partial breast irradiation for early stage ductal breast cancer may be adequate
- Pathological complete response after chemotherapy predicts favorable outcome
- Patients of surgeons with high volume of breast cancer cases have better survival
- Patients with ER-/PR+ breast cancer benefit from endocrine therapy
- Physical activity increases survival in postmenopausal breast cancer patients
- Positive lymph nodes reduce breast cancer survival, especially among old women
- Prediagnostic enterolactone levels linked to lower mortality among women with breast cancer
- Preliminary study finds Boniva can eradicate dormant breast cancer cells in bone marrow
- Prognostic significance of number of positive axillary lymph nodes
- Prozac might influence brain metastasis in breast cancer survivors
- Radiation after lumpectomy reduces recurrence for DCIS survivors
- Radiation treatment after lumpectomy significantly reduces long-term recurrence and death
- Radiation treatment may improve prognosis of early stage triple negative breast cancer
- Recent improvements in breast cancer survival do not extend to old women
- Regular breast cancer surveillance should continue years after lumpectomy
- Removing ovaries during second half of menstrual cycle improves survival
- Residual cancer after chemotherapy
- Response to neoadjuvant chemotherapy depends on dosage and tumor type
- Risk of second primary breast cancer highest in hormone receptor negative survivors
- Screening mammograms are less accurate in breast cancer survivors
- Screening mammograms are most accurate during first week of menstrual cycle
- Second breast cancer highly likely among women with ER- tumors and/or family history
- Sentinel node micrometastases do not reduce breast cancer survival in early years
- Simultaneous chemotherapy plus radiation treatment reduces breast cancer recurrence
- Skin-sparing mastectomy not linked to increased breast cancer recurrence
- Small amount of alcohol after diagnosis does not reduce survival
- Small triple negative tumors have worse prognosis than small ER+/PR+ tumors
- Some older women with early stage breast cancer do well without surgery
- Some women with close margins after lumpectomy face increased risk of recurrence
- Soy food consumption is not linked to worse breast cancer prognosis
- Strongly estrogen positive lobular breast cancer responds well to neoadjuvant Femara
- Surgery to remove breasts and ovaries reduces cancer risks among BRCA1/2 carriers
- Survival after local recurrence is higher in women originally diagnosed under 50 years of age
- Survival times for metastatic breast cancer have been improving
- Survival times of stage IV breast cancer patients depends on progesterone receptor status
- Taking aspirin improves breast cancer survival
- Taking tamoxifen for all 5 years reduces long-term risk of breast cancer recurrence
- The beta blocker propranolol increases the effectiveness of Taxol
- The bisphosphonate zoledronic acid might reduce breast cancer recurrence in postmenopausal women
- Treatment with Herceptin for one year improves survival in women with HER2+ breast cancer
- Triple negative breast cancer in BRCA1 mutation carriers and noncarriers has similar prognosis
- Triple negative breast cancer incidence and recurrence patterns in a Latina population
- Triple negative breast cancer involves increased risk of distant relapse within shorter time
- Triple negative breast cancer prognosis is influenced even by small number of positive nodes
- Tumor marker CA 27.29 has limited usefulness in determining initial prognosis
- Tumor response to anti-estrogen treatment before surgery is influenced by BMI and race
- Underweight women have higher risks of breast cancer recurrence and metastasis
- Undetected lymph node micrometastases do not greatly reduce overall survival
- Use of aspirin and other NSAIDs before diagnosis does not improve breast cancer survival
- Use of statins improves breast cancer outcomes in women with type 2 diabetes
- Use of the statin Zocor is associated with lower risk of breast cancer recurrence
- Use of vitamin C and vitamin E is associated with less breast cancer recurrence
- Vitamin C intake is not associated with risk of breast cancer
- Vitamin D deficiency promotes growth of breast cancer bone metastases
- Weight gain is common after breast cancer
- Women diagnosed before age 36 have higher risk of relapse than somewhat older women
- Women who are physically active may be more likely to survive breast cancer
- Women with dense breasts have higher risk of local breast cancer recurrence
- Women with high BMI may benefit less from hormonal treatments
- Women with parent who died of breast cancer are also more likely to die if diagnosed
- Worse prognosis for breast cancer after lumpectomy with positive margins
- Young breast cancer patients require aggressive treatment
Studies